The treatment has been developed to treat certain chronic heart failure patients and is approved elsewhere

The pathway is a programme designed to develop pharmacists’ knowledge of mental health among patients

Updated Date: Tue, 31 Jan 2023 00:00:00 EST

Financing will allow company’s development of DNA synthesis chip technology to commercial scale

Milestone therapy concerns the treatment of patients with symptomatic chronic heart failure

Researchers have used single carbon atom doping to form four chemical bonds in one step. Gamma-lactams (cyclic molecules […]

Alvotech will be responsible for supply and Advanz will oversee commercialisation of biosimilar

Charity highlights the need to find kidney cancer early and for better guidance among doctors

PharmaTimes announces the launch of the 2023 event and hopes to see returning contestants from previous years as […]

MHRA approval for Rinvoq which treats adults with moderate to severely active Crohn’s Disease